119 related articles for article (PubMed ID: 17762173)
21. 8-cyclopentyl-1,3-dipropylxanthine and other xanthines differentially bind to the wild-type and delta F508 first nucleotide binding fold (NBF-1) domains of the cystic fibrosis transmembrane conductance regulator.
Cohen BE; Lee G; Jacobson KA; Kim YC; Huang Z; Sorscher EJ; Pollard HB
Biochemistry; 1997 May; 36(21):6455-61. PubMed ID: 9174362
[TBL] [Abstract][Full Text] [Related]
22. Calcium-pump inhibitors induce functional surface expression of Delta F508-CFTR protein in cystic fibrosis epithelial cells.
Egan ME; Glöckner-Pagel J; Ambrose C; Cahill PA; Pappoe L; Balamuth N; Cho E; Canny S; Wagner CA; Geibel J; Caplan MJ
Nat Med; 2002 May; 8(5):485-92. PubMed ID: 11984593
[TBL] [Abstract][Full Text] [Related]
23. A mouse model for the delta F508 allele of cystic fibrosis.
Zeiher BG; Eichwald E; Zabner J; Smith JJ; Puga AP; McCray PB; Capecchi MR; Welsh MJ; Thomas KR
J Clin Invest; 1995 Oct; 96(4):2051-64. PubMed ID: 7560099
[TBL] [Abstract][Full Text] [Related]
24. Identification of revertants for the cystic fibrosis delta F508 mutation using STE6-CFTR chimeras in yeast.
Teem JL; Berger HA; Ostedgaard LS; Rich DP; Tsui LC; Welsh MJ
Cell; 1993 Apr; 73(2):335-46. PubMed ID: 7682896
[TBL] [Abstract][Full Text] [Related]
25. The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR.
Du K; Sharma M; Lukacs GL
Nat Struct Mol Biol; 2005 Jan; 12(1):17-25. PubMed ID: 15619635
[TBL] [Abstract][Full Text] [Related]
26. Cystic fibrosis transmembrane conductance regulator trafficking modulates the barrier function of airway epithelial cell monolayers.
LeSimple P; Liao J; Robert R; Gruenert DC; Hanrahan JW
J Physiol; 2010 Apr; 588(Pt 8):1195-209. PubMed ID: 20156845
[TBL] [Abstract][Full Text] [Related]
27. Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator.
Younger JM; Chen L; Ren HY; Rosser MF; Turnbull EL; Fan CY; Patterson C; Cyr DM
Cell; 2006 Aug; 126(3):571-82. PubMed ID: 16901789
[TBL] [Abstract][Full Text] [Related]
28. Normal function of the cystic fibrosis conductance regulator protein can be associated with homozygous (Delta)F508 mutation.
Sermet-Gaudelus I; Vallée B; Urbin I; Torossi T; Marianovski R; Fajac A; Feuillet MN; Bresson JL; Lenoir G; Bernaudin JF; Edelman A
Pediatr Res; 2002 Nov; 52(5):628-35. PubMed ID: 12409506
[TBL] [Abstract][Full Text] [Related]
29. Introduction of the most common cystic fibrosis mutation (Delta F508) into human P-glycoprotein disrupts packing of the transmembrane segments.
Loo TW; Bartlett MC; Clarke DM
J Biol Chem; 2002 Aug; 277(31):27585-8. PubMed ID: 12070134
[TBL] [Abstract][Full Text] [Related]
30. In vivo activation of the cystic fibrosis transmembrane conductance regulator mutant deltaF508 in murine nasal epithelium.
Kelley TJ; Thomas K; Milgram LJ; Drumm ML
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2604-8. PubMed ID: 9122242
[TBL] [Abstract][Full Text] [Related]
31. Cysteine string protein monitors late steps in cystic fibrosis transmembrane conductance regulator biogenesis.
Zhang H; Schmidt BZ; Sun F; Condliffe SB; Butterworth MB; Youker RT; Brodsky JL; Aridor M; Frizzell RA
J Biol Chem; 2006 Apr; 281(16):11312-21. PubMed ID: 16469739
[TBL] [Abstract][Full Text] [Related]
32. Ultrastructural localization of variant forms of cystic fibrosis transmembrane conductance regulator in human bronchial epithelial of xenografts.
Yang Y; Engelhardt JF; Wilson JM
Am J Respir Cell Mol Biol; 1994 Jul; 11(1):7-15. PubMed ID: 7517144
[TBL] [Abstract][Full Text] [Related]
33. Effects of the delta F508 mutation on the structure, function, and folding of the first nucleotide-binding domain of CFTR.
Thomas PJ; Pedersen PL
J Bioenerg Biomembr; 1993 Feb; 25(1):11-9. PubMed ID: 7680027
[TBL] [Abstract][Full Text] [Related]
34. Protection against bronchial asthma by CFTR delta F508 mutation: a heterozygote advantage in cystic fibrosis.
Schroeder SA; Gaughan DM; Swift M
Nat Med; 1995 Jul; 1(7):703-5. PubMed ID: 7585155
[TBL] [Abstract][Full Text] [Related]
35. Strategies for correcting the delta F508 CFTR protein-folding defect.
Brown CR; Hong-Brown LQ; Welch WJ
J Bioenerg Biomembr; 1997 Oct; 29(5):491-502. PubMed ID: 9511934
[TBL] [Abstract][Full Text] [Related]
36. The Delta F508 mutation shortens the biochemical half-life of plasma membrane CFTR in polarized epithelial cells.
Heda GD; Tanwani M; Marino CR
Am J Physiol Cell Physiol; 2001 Jan; 280(1):C166-74. PubMed ID: 11121388
[TBL] [Abstract][Full Text] [Related]
37. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation.
Sato S; Ward CL; Krouse ME; Wine JJ; Kopito RR
J Biol Chem; 1996 Jan; 271(2):635-8. PubMed ID: 8557666
[TBL] [Abstract][Full Text] [Related]
38. [Frequency of mutations and genotypes of the CFTR gene in cystic fibrosis adults in Poland].
Witt M; Pogorzelski A; Bal J; Rutkiewicz E; Majka L; Sobczyńska A
Pneumonol Alergol Pol; 1999; 67(3-4):137-41. PubMed ID: 10497446
[TBL] [Abstract][Full Text] [Related]
39. Assembly and misassembly of cystic fibrosis transmembrane conductance regulator: folding defects caused by deletion of F508 occur before and after the calnexin-dependent association of membrane spanning domain (MSD) 1 and MSD2.
Rosser MF; Grove DE; Chen L; Cyr DM
Mol Biol Cell; 2008 Nov; 19(11):4570-9. PubMed ID: 18716059
[TBL] [Abstract][Full Text] [Related]
40. Post-translational disruption of the delta F508 cystic fibrosis transmembrane conductance regulator (CFTR)-molecular chaperone complex with geldanamycin stabilizes delta F508 CFTR in the rabbit reticulocyte lysate.
Fuller W; Cuthbert AW
J Biol Chem; 2000 Dec; 275(48):37462-8. PubMed ID: 10982807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
